Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Minuk

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Canadian Liver Journal|July 18, 2025
Response to Commentary on Ragheb et alNabiha Faisal, Gerald Minuk
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2020
Chronic Liver Disease and Metabolic Comorbidities in Healthy Young Males Followed for 65 Years: The Manitoba Follow-up StudyJulia Uhanova, Meaghan O'Brien, Gerald Minuk, et al.
Canadian Liver Journal|August 22, 2022
Serial liver transaminases have no prognostic value in non-alcoholic fatty liver diseaseJulia Uhanova, Gerald Minuk, Kamila Premji, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver diseaseNatasha Chandok, Gerald Minuk, Matias Wengiel, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 17, 2007
Apoptotic and survival signals in hepatic stellate cellsHong Shen, Jianghong Fan, Gerald Minuk, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations PatientsJulia Uhanova, Gerald Minuk, Federico Lopez Ficher, et al.
Canadian Liver Journal|August 22, 2022
Serum immunoglobulin A levels and non-alcoholic fatty liver diseaseEvan Elias, Julia Uhanova, Qian Li, et al.
Canadian Liver Journal|May 15, 2024
Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver diseaseMariam Ragheb, Micah Grubert Van Iderstine, Gerald Minuk, et al.
Canadian Journal of Physiology and Pharmacology|January 4, 2014
Membrane potential differences and GABAA receptor expression in hepatic tumor and non-tumor stem cellsWendy Bautista, Victor Perez-Alvarez, Frank Burczynski, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 2018
Predicting Pre-transplant Abstinence in Patients with Alcohol-Induced Liver DiseaseAnnie Gong, Samantha Leitold, Julia Uhanova, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Canadian Liver Journal|July 18, 2025
Response to Commentary on Ragheb et alNabiha Faisal, Gerald Minuk
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2020
Chronic Liver Disease and Metabolic Comorbidities in Healthy Young Males Followed for 65 Years: The Manitoba Follow-up StudyJulia Uhanova, Meaghan O'Brien, Gerald Minuk, et al.
Canadian Liver Journal|August 22, 2022
Serial liver transaminases have no prognostic value in non-alcoholic fatty liver diseaseJulia Uhanova, Gerald Minuk, Kamila Premji, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver diseaseNatasha Chandok, Gerald Minuk, Matias Wengiel, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 17, 2007
Apoptotic and survival signals in hepatic stellate cellsHong Shen, Jianghong Fan, Gerald Minuk, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations PatientsJulia Uhanova, Gerald Minuk, Federico Lopez Ficher, et al.
Canadian Liver Journal|August 22, 2022
Serum immunoglobulin A levels and non-alcoholic fatty liver diseaseEvan Elias, Julia Uhanova, Qian Li, et al.
Canadian Liver Journal|May 15, 2024
Exploring autoantibodies as predictors of severe fibrosis or cirrhosis in metabolic dysfunction associated with steatotic liver diseaseMariam Ragheb, Micah Grubert Van Iderstine, Gerald Minuk, et al.
Canadian Journal of Physiology and Pharmacology|January 4, 2014
Membrane potential differences and GABAA receptor expression in hepatic tumor and non-tumor stem cellsWendy Bautista, Victor Perez-Alvarez, Frank Burczynski, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 1, 2018
Predicting Pre-transplant Abstinence in Patients with Alcohol-Induced Liver DiseaseAnnie Gong, Samantha Leitold, Julia Uhanova, et al.
Pageof 3